SCHEMBL29985396

SCHEMBL29985396

Cc1cnc2cc(C(=O)O)ccc2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.64
RAB9A P51151 5/20 0.54
NPC1 O15118 4/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 4/20 0.54
HPGD P15428 4/20 0.54
GAA P10253 3/20 0.54
MAPT P10636 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
HSP90AA1 P07900 1/20 0.49
ESR2 Q92731 1/20 0.49
CDH1 P12830 1/20 0.46
APC P25054 1/20 0.46
CTNNB1 P35222 1/20 0.46
TCF7L2 Q9NQB0 1/20 0.46
MGAM O43451 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
HTT P42858 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629411 1.00 TDP1 (0.64) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL2629412 0.93 TDP1 (0.64) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL30134026 0.86 TDP1 (0.46) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL14741522 0.85 KMT2A (0.46) TDP1RAB9ANPC1KMT2AKDM4E
SCHEMBL11088871 0.81 ALDH1A1 (0.62) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL29967657 0.79 TDP1 (0.54) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL21863476 0.79 TDP1 (0.54) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL22237575 0.79 TDP1 (0.46) TDP1RAB9ANPC1ALDH1A1KDM4E
SCHEMBL1574747 0.79 TDP1 (0.54) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL21264207 0.79 TDP1 (0.54) TDP1RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597728-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-03-07 US disclosed
US-20220315583-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597728-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP TDP1 1309/4885RAB9A 994/4885NPC1 826/4885
US-20220315583-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP TDP1 1309/4885RAB9A 994/4885NPC1 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.